Table 3.
Univariable model | Multivariable model* | |
---|---|---|
Base outcome: cardioembolic | OR (95% CI) | aOR (95% CI) |
Non-cardioembolic | ||
RBC | 1.03 (1.01; 1.05) | 1.02 (1.00; 1.04) |
F/P | 0.97 (0.95; 0.99) | 0.98 (0.96; 1.00) |
Leukocytes | 0.91 (0.83; 1.01) | 0.90 (0.81; 1.01) |
Undetermined | ||
RBC | 1.00 (0.99; 1.01) | 1.00 (0.98; 1.01) |
F/P | 1.00 (0.99; 1.01) | 1.00 (0.99; 1.02) |
Leukocytes | 1.00 (0.94; 1.07) | 1.00 (0.92; 1.06) |
All analyses were done with thrombus components as a continuous variable, expressed as % of the thrombus. Odds ratios for stroke etiology are shown per percentage increase of thrombus components, with 95% confidence intervals. Interpretation: for every 1% increase in RBCs, OR for a non-cardioembolic stroke (compared with cardioembolic stroke) is 1.03 (95% CI 1.01–1.05). Non-cardioembolic indicates TOAST 1 (large artery sclerosis) + TOAST 4 (other determined cause)
RBC red blood cells, F/P fibrin/platelets, and leukocytes white blood cells
*Adjusted for: age, sex, IV thrombolysis, coumarin/DOAC use, and thrombus location